These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 5133132

  • 1. [Features of hypotensive therapy in patients with chronic renal insufficiency].
    Glezer GA, Ratner NA, Charyev M.
    Klin Med (Mosk); 1971 Oct; 49(10):110-6. PubMed ID: 5133132
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Controlled blood pressure reduction in chronic renal insufficiency].
    Buder HW, Precht K.
    Dtsch Gesundheitsw; 1968 May 09; 23(19):879-81. PubMed ID: 5678843
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic modalities of hypertension in patients in a state of chronic kidney insufficiency].
    Fillastre JP, Leroy J, Dubois D.
    Coeur Med Interne; 1971 May 09; 10(2):247-51. PubMed ID: 5568267
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Use of antihypertensives in advanced renal insufficiency].
    Gasparović V.
    Lijec Vjesn; 1985 May 09; 107(5):217-8. PubMed ID: 4010455
    [No Abstract] [Full Text] [Related]

  • 7. Effects of blood pressure control on the progression of renal insufficiency in chronic renal failure.
    Branca GF, Satta A, Faedda R, Soggia G, Olmeo NA, Vacca R, Bartoli E.
    Panminerva Med; 1983 May 09; 25(4):215-8. PubMed ID: 6672713
    [No Abstract] [Full Text] [Related]

  • 8. [Antihypertensive therapy in limited renal function].
    Lübbecke F.
    Fortschr Med; 1986 Nov 13; 104(42):793-6. PubMed ID: 3804151
    [No Abstract] [Full Text] [Related]

  • 9. [The effect of hypotensive and pathogenetic therapy on the propulsive function of the heart in patients with glomerulonephritis].
    Zharko KP, Tarnakina TP, Akhmed DI.
    Vrach Delo; 1989 Sep 13; (9):71-3. PubMed ID: 2609629
    [Abstract] [Full Text] [Related]

  • 10. [Arterial hypertension caused by chronic renal insufficiency. Pathogenesis and treatment].
    Niculescu P.
    Rev Med Chir Soc Med Nat Iasi; 1975 Sep 13; 79(1):13-8. PubMed ID: 1144971
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K, Kanazawa M, Sato T, Abe F, Saito T, Abe K.
    Kidney Int Suppl; 1996 Jun 13; 55():S57-62. PubMed ID: 8743512
    [Abstract] [Full Text] [Related]

  • 12. [May medical therapy of arterial hypertension by used in patients with renal failure?].
    Richet G, Ducrot H, Hamburger J, Legrain M, Maxwell M, Péquignot MH.
    Presse Med (1893); 1968 Nov 16; 76(44):2103-6. PubMed ID: 5701039
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment and prognosis of renal hypertension].
    Oshima K, Takeda T, Fukuchi S, Abe K, Kajiwara N.
    Jpn Circ J; 1974 Apr 16; 38():Suppl:93-7. PubMed ID: 4406378
    [No Abstract] [Full Text] [Related]

  • 14. [Causes of arterial hypertension and tactics of its treatment in chronic renal insufficiency at the terminal stage].
    Mazo EB, Maĭdanov ET.
    Sov Med; 1975 Jul 16; (7):22-6. PubMed ID: 1216044
    [No Abstract] [Full Text] [Related]

  • 15. Slowing down chronic renal failure progression with various antihypertensive agents.
    Jovanović DB, Djukanović L, Naumović R.
    Clin Nephrol; 1998 Dec 16; 50(6):390-2. PubMed ID: 9877115
    [No Abstract] [Full Text] [Related]

  • 16. [Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
    Nestor G, Beroniade V, Tutunaru M.
    Med Interna (Bucur); 1970 Jul 16; 22(7):863-8. PubMed ID: 5479504
    [No Abstract] [Full Text] [Related]

  • 17. Long-term effects of endralazine (BQ-22-708) in patients with renal impairment and hypertension.
    Kingswood JC, Harrison PR, Banks RA, Higgs E, Mackenzie JC.
    Postgrad Med J; 1983 Jul 16; 59 Suppl 3():173-6. PubMed ID: 6647204
    [Abstract] [Full Text] [Related]

  • 18. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
    Kotzaurek R, Schmidt P, Widhalm F.
    Wien Klin Wochenschr; 1970 Nov 06; 82(45):805-9. PubMed ID: 5479019
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of hypotensive therapy on kidney function in hypertensive states].
    Shershnev VG, Shcherban' NN, Gorodetskiĭ AL.
    Ter Arkh; 1973 Oct 06; 45(10):85-8. PubMed ID: 4783250
    [No Abstract] [Full Text] [Related]

  • 20. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep 06; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.